Physician profile
Ciro J Carafa
NPI 1154485449
$1,456.74
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2020: $82.15 · 2021: $382 · 2022: $446 · 2023: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.30 | 2021-2023 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $207.58 | 2020-2023 | Trelegy Ellipta, Shingrix |
| Pfizer INC. | $131.23 | 2021-2023 | |
| Astellas Pharma US INC | $128.51 | 2019-2022 | |
| Amarin Pharma, INC. | $107.54 | 2020-2021 | |
| Lilly USA, LLC | $75.27 | 2021-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $69.13 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $52.29 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.98 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.65 | 2022-2023 | Trulance, Xifaxan |
| Hikma Pharmaceuticals USA | $34.80 | 2022 | |
| Abbott Laboratories | $25.92 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2022 | |
| Horizon Therapeutics Plc | $14.44 | 2021 | |
| Amgen INC. | $14.07 | 2023 | Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.50 | 2021 | |
| Abbvie INC. | $13.27 | 2021 | |
| Janssen Biotech, INC. | $12.37 | 2022 | |
| Smith+Nephew, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ciro Carafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.